Cancer IT Systems (Global Market)

2024: Global Oncology Software Market Size Reaches $2.7 Billion for the Year

In 2024, expenditures in the global oncology software market reached $2.7 billion. About 40% of this amount fell on the North American region. Such data are provided in a Fortune Business Insights study, the results of which were published in April 2025.

Analysts are considering specialized software that helps in the planning and implementation of cancer treatment, including chemotherapy, targeted therapy, immunotherapy and hormone therapy. Such software allows oncologists to manage patient data, generate drug schedules, monitor side effects, etc.

One of the drivers of the market in question is the growing propensity of health care providers for personalized therapy. Its development is facilitated by artificial intelligence and machine learning technologies. AI algorithms are able to analyze huge amounts of data to form the optimal treatment plan. These tools can integrate and process information from a variety of sources, such as medical records, imaging data, etc. In addition, generative AI can predict patient outcomes by analyzing historical indicators and identifying risk factors. The software issues personalized treatment recommendations, including specific drugs, dosage, and regimens, according to each patient's genetics.

Analysts cite the increasing number of new cancer cases as another factor in the growth. This trend places a huge burden on the health care system around the world. As a result, the need for specialized software for medical oncology is increasing, which helps to manage the patient pool and treatment processes. The integration of such software with other medical systems allows you to increase the efficiency of institutions in the healthcare sector, reduce costs and improve the quality of patient care.

Among the restraining factors, the authors of the study cite safety issues. Hackers are increasingly introducing malware with encryption functions into the IT infrastructure of medical organizations for subsequent blackmail and ransom demands. A growing number of cyber threats, including ransomware, phishing attacks, and leaks, require the deployment of robust intrusion detection and prevention tools.

According to the software usage model, the market is segmented into cloud, local and hybrid sectors. In 2024, the lion's share of revenue was provided by the first of the listed areas - 53.9%. Cloud solutions are dominated by scalability, availability, and low upfront costs. At the same time, local products prefer those organizations that need maximum control over data and operations. Hybrid platforms combine the benefits of cloud and local systems. Geographically, North America leads, accounting for $1.1 billion, or 40.7% of global costs. Globally, significant players are named:

• Epic Systems;
• Altai;
• Varian Medical Systems Siemens Healthineers ( AG);
• Cerner Corporation ( Oracle );
• American Medical Software;
• Elekta;
• EndoSoft;
• RaySearch Laboratories;
• Mckesson Corporation;
• Koninklijke Philips N.V.

Fortune Business Insights analysts believe that in the future, the CAGR in the market under consideration will be 8.4%. As a result, by 2032, costs could increase to $5.06 billion.^[1]

2017: Transparency Market Research Data

In April 2017, the analytical company Transparency Market Research published a study of the global market for information systems used in oncology.

According to experts, the demand for cancer IT systems is increasing as technologies are developed and implemented, health infrastructure in developing countries is improved, the prevalence of metastases as a result of cancer is increasing, and the overall increase in the number of cancer patients.

Elekta Cancer Center Software

Information support systems using modern computing equipment are increasingly used in various branches of medicine and healthcare. The cancer service is no exception. However, there is no systematic approach or unified ideology in the informatization of the oncological service.

The need to develop system information support for medical technologies is clear. All issues of management, resource support, expertise should be resolved on the basis of information reflected in the medical technological process. The informatization and computerization of medical technologies in some cases involves a radical change in the technology of the doctor's work with the patient, algorithms, methods for collecting, processing information and making control decisions, the study says.

The following companies are called the largest developers of cancer IT systems by analysts:

• CureMD Healthcare;
• Varian Medical Systems;
• Flatiron Health;
• Epic Systems;
• Bogardus Medical Systems;
• Cerner Corporation;
• McKesson;
• Philips;
• Elekta;
• Accuray.

In terms of products, the cancer IT systems market at Transparency Market Research is divided into patient information solutions and systems for treatment planning, optimization, implementation, support and maintenance solutions.^[2]

Notes